Although SOX2 expression tends to have an unfavorable impact on patient prognosis in the majority of cancer types, it is also linked to a favorable prognosis in at least four types of cancer including gastric, head and neck squamous carcinoma, lung SCC, and ovarian cancers (as reviewed in [9]). Here, SOX2 is linked to ovarian carcinoma.